Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FMT for Constipation in Parkinson's Disease
NCT06388863Recruiting
- Sponsor
- Zhongshan Hospital, Fudan University
- Start
- Feb 2025
- Primary completion
- Dec 2026
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
Randomised, double-blind trial in constipation comparing FMT capsule group with Placebo capsule group (2 arms). Primary endpoint: Response rate of constipation in Parkinson's Disease at 24 weeks. Started Feb 2025; status: recruiting.
02
Drugs
Fecal Microbiota Transplantation Capsule
03
Conditions
constipation
Beyond the preview
Go deeper on NCT06388863.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06388863.